Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Published:2019-12 Issue:12 Volume:30 Page:1950-1958
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Morizane C.^ORCID,Okusaka T.,Mizusawa J.,Katayama H.,Ueno M.,Ikeda M.,Ozaka M.,Okano N.,Sugimori K.,Fukutomi A.,Hara H.,Mizuno N.,Yanagimoto H.,Wada K.,Tobimatsu K.,Yane K.,Nakamori S.,Yamaguchi H.,Asagi A.,Yukisawa S.,Kojima Y.,Kawabe K.,Kawamoto Y.,Sugimoto R.,Iwai T.,Nakamura K.,Miyakawa H.,Yamashita T.,Hosokawa A.,Ioka T.,Kato N.,Shioji K.,Shimizu K.,Nakagohri T.,Kamata K.,Ishii H.,Furuse J.

Funder

National Cancer Center Research and Development Funds

Japan Agency for Medical Research and Development

Grant-in-Aid for Clinical Cancer Research

Ministry of Health, Labor, and Welfare of Japan

Agency for Medical Research and Development

AMED

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz402/30225666/mdz402.pdf

Reference22 articles.

1. International agency for research on cancer;Ferlay;Cancer Today,2018

2. Biliary tract cancer registry in Japan from 2008 to 2013;Ishihara;J Hepatobiliary Pancreat Sci,2016

3. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

4. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan;Okusaka;Br J Cancer,2010

5. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study;Furuse;Cancer Chemother Pharmacol,2008

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidental gallbladder cancer detected during laparoscopic cholecystectomy: conversion to extensive resection is a feasible choice;Frontiers in Surgery;2024-09-05

2. Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration;Cancer Immunology, Immunotherapy;2024-09-05

3. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

4. New perspectives in biliary tract cancers;ESMO Gastrointestinal Oncology;2024-09

5. Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer;Journal of Gastrointestinal Cancer;2024-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3